Publications-Periodical Articles

Showing 1-25 of 46
Date Title Type Full Text
2023-05 NMDA receptor glycine binding site modulators for prevention and treatment of ketamine use disorder article web page(172)
2022-11 Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT1A receptors article web page(158)
2022-11 L-4-Fluorophenylglycine produces antidepressant-like effects and enhances resilience to stress in mice article web page(243)
2021-12 Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice article web page(244)
2021-10 Betaine supplementation to rats alleviates disturbances induced by high-fat diet: pleiotropic effects in model of type 2 diabetes article web page(195)
2021-09 N, N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice article web page(177)
2021-07 Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes article pdf(207)
2020-12 Increased behavioral and neuronal responses to a hallucinogenic drug after adolescent toluene exposure in mice: effects of antipsychotic treatment article pdf(239)
2020-12 N,Ndimethylglycine prevents toluene-induced impairment in recognition memory and synaptic plasticity in mice article pdf(233)
2020-06 Effectiveness in the block by honokiol. A dimerized allylphenol from Magnonia officinalis, of Hyperpolarization-activated cation current and delayed-rectifier K current article pdf(205)
2018-12 Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARr regulation article pdf(479)
2018-09 Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice article pdf(598)
2018-08 Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease article pdf(433)
2018-08 Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats article pdf(469)
2018 Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease article pdf(563)
2018 Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine article web page(1121)
2017-12 Effect of Pachybasin on General Toxicity and Developmental Toxicity in Vivo article web page(912)
2017-03 Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson`s disease using in vivo18 F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging article pdf(506)
2017-03 Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. article pdf(543)
2017 Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels article web page(953)
2017 Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials article pdf(899)
2016-11 N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice article pdf(468)
2016-10 Extracellular calcium concentration and channel activity involved in aminoglycoside-induced hair cell toxicity in the zebrafish lateral line article pdf(606)
2016-10 Acute and subchronic effects of antipsychotic drugs on cognitive and social deficits after adolescent toluene exposure in mice article pdf(511)
2016-09 Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice article pdf(626)